Market News

Stay updated with the latest market trends, earnings, and economic indicators.

Showing news for:MONIFTY100Healthcare
Clear all filters
Neutral ALKEM Laboratories; target of Rs 5840: Motilal Oswal
positive
Moneycontrol NaNd ago

Neutral ALKEM Laboratories; target of Rs 5840: Motilal Oswal

Motilal Oswal recommended Neutral rating on ALKEM Laboratories with a target price of Rs 5840 in its research report dated May 28, 2026.

ALKEMMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEFinancial ServicesHealthcare
Buy Dr Agarwals Health Care; target of Rs 610: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Dr Agarwals Health Care; target of Rs 610: Motilal Oswal

Motilal Oswal is bullish on Dr Agarwals Health Care recommended buy rating on the stock with a target price of Rs 610 in its research report dated Jun 05, 2026.

AGARWALEYEAMRUTANJANMEDANTAMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEPGHHZOTAFast Moving Consumer GoodsFinancial Services
Buy Piramal Pharma; target of Rs 190: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Piramal Pharma; target of Rs 190: Motilal Oswal

Motilal Oswal is bullish on Piramal Pharma has recommended buy rating on the stock with a target price of Rs 190 in its research report dated April 29, 2026.

MOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEPPLPHARMASPARCFinancial ServicesHealthcare
Buy Rubicon Research; target of Rs 955: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Rubicon Research; target of Rs 955: Motilal Oswal

Motilal Oswal is bullish on Rubicon Research recommended buy rating on the stock with a target price of Rs 955 in its research report dated April 15, 2026.

MOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUERUBICONFinancial ServicesHealthcare
SBI MF, Nippon India MF buy Rs 272 crore worth Pine Labs shares; ICICI Pru MF acquire 1.5% stake in Indoco Remedies
positive
Moneycontrol NaNd ago

SBI MF, Nippon India MF buy Rs 272 crore worth Pine Labs shares; ICICI Pru MF acquire 1.5% stake in Indoco Remedies

SBI Mutual Fund through SBI Midcap Fund held 5.24 percent stake in Pine Labs, the point of sale and payment systems provider, as of March 2026.

ABSLPSEALPHAALPHAETFAONEGOLDAONELIQUIDAONENIFTYAONESILVERAONETOTALAUTOBEESAUTOIETFAXISBPSETFBANK10ADDBANKADDBANKBETFBANKETFBANKPSUBBETF0432BBNPNBETFBBNPPGOLDBFSIBNKETFAXISCHEMICALCHOICEGOLDCOMMOIETFCONSUMAXISDEFENCEDIVIDENDEBANKNIFTYEBBETF0430EBBETF0431EBBETF0433ECAPINSUREEGOLDELIQUIDELM250ENERGYENIFTYEQUAL200EQUAL50EQUAL50ADDESENSEXESGESILVERFINIETFFLEXIADDFMCGADDFMCGIETFGILT10BETAGILT5BETAGOLD1GOLD360GOLDADDGOLDAXISGOLDBETAGOLDBNDGOLDETFGROWWCAPMGROWWCHEMGROWWDEFNCGROWWEVGROWWGOLDGROWWHOSPIGROWWLIQIDGROWWLOVOLGROWWMC150GROWWMETALGROWWMOM50GROWWN200GROWWNETGROWWNIFTYGROWWNXT50GROWWPOWERGROWWPSEGROWWPSUBKGROWWRAILGROWWRLTYGROWWSC250GROWWSLVRGSEC10IETFGSEC10YEARHDFCGOLDHDFCGROWTHHDFCLOWVOLHDFCMID150HDFCMOMENTHDFCNEXT50HDFCNIF100HDFCNIFITHDFCPSUBKHDFCPVTBANHDFCQUALHDFCSILVERHDFCSML250HDFCVALUEHEALTHADDHEALTHAXISHEALTHCAREHEALTHIETFHSBCGOLDICICIB22INDOCOINFRAIETFINTERNETITADDITAXISITBEESITBETAITETFITIETFLICNETFSENLICNMID100LIQGRWBEESLIQUIDLIQUID1LIQUIDPLUSLIQUIDSBILIQUIDSHRILOWVOLMAFANGMAHKTECHMAKEINDIAMANUFGBEESMASPTOP50METALMETALIETFMID150MID150BEESMID150CASEMIDCAPMIDCAPADDMIDCAPBETAMIDCAPETFMIDCAPIETFMIDQ50ADDMIDSELIETFMNCMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM30IETFMOM50MOMENTUMMOMENTUM30MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTOURMOVALUEMSCIADDMSCIINDIAMULTICAPNEXT30ADDNEXT50NEXT50ADDNEXT50BETANEXT50ETFNEXT50IETFNIFTY100EWNIFTYADDNIFTYAXISNIFTYBETFNIFTYETFNIFTYQLITYOILIETFPHARMABEESPINELABSPSUBANKADDPSUBNKIETFPVTBANKADDQUALITY30RSYSTEMSSBIBPBSBICARDSBIETFCONSBIETFITSBIETFPBSBIETFQLTYSBILIQETFSBINEQWETFSBINMID150SBISILVERSDL26BEESSELECTIPOSENSEXAXISSENSEXETFSETF10GILTSILVERSILVER1SILVER360SILVERADDSILVERAGSILVERAXISSILVERBEESSILVERBETASILVERBNDSILVERIETFSMALL250SMALLADDSNXT30BEESTATAGOLDTATSILVTECHTNIDETFTOP10ADDTOP20TWCGOLDETFUNIONGOLDVAL30IETFVALUEVALUEAXISFinancial ServicesHealthcare
Taking Stock: Markets rally for 5th straight day; Sensex, Nifty soar 4% on ceasefire deal
positive
Moneycontrol NaNd ago

Taking Stock: Markets rally for 5th straight day; Sensex, Nifty soar 4% on ceasefire deal

Nearly 100 stocks touched their 52-week high on the BSE, including Adani Energy, Titan Company, ABB India, Natco Pharma, SAIL, Anand Rathi, Aurobindo Pharma, Godawari Power, Granules India, CCL Products, among others.

ABBADANIENSOLADANIENTADANIGREENADANIPOWERANANDRATHIARSSBLAUROPHARMABSEBSLSENETFGCCLDPELECAPINSUREENERGYESENSEXESGGKENERGYGPILGRANULESGROWWCAPMGROWWPOWERGVPILHDFCNIF100HDFCSENSEXHONDAPOWERKPELLICNFNHGPLICNMID100LOWVOLLOWVOL1LOWVOLIETFMIDSMALLMOENERGYMONIFTY100NATCOPHARMNEXT30ADDNIF100BEESNIF100IETFNIFTY100EWPHARMABEESSAILSENSEXADDSENSEXAXISSENSEXBETASENSEXETFSENSEXIETFSMALLCAPSML100CASESNXT30BEESSNXT50BETATITANTOP100CASECapital GoodsConstruction
Buy Mankind Pharma; target of Rs 2640: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Mankind Pharma; target of Rs 2640: Motilal Oswal

Motilal Oswal is bullish on Mankind Pharma has recommended buy rating on the stock with a target price of Rs 2640 in its research report dated April 29, 2026.

MANKINDMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUESPARCFinancial ServicesHealthcare
Closing Bell: Nifty above 23,100, Sensex gain 509 pts; IT, metal, realty shine
positive
Moneycontrol NaNd ago

Closing Bell: Nifty above 23,100, Sensex gain 509 pts; IT, metal, realty shine

Biggest Nifty gainers were Wipro, Hindalco Industries, HCL Technologies, TCS, Infosys, while losers included Dr Reddy's Laboratories, Adani Enterprises, Interglobe Aviatoion, Apollo Hospitals, Adani Ports. Except Consumer Durables and PSU Bank, all other sectoral indices ended in the green with Information Technology rose 2.5%, Metal index gained 1.5%, Realty index up 1.7% and Media index jumped 1%. The Nifty midcap index was up 0.3 percent, while smallcap index ended flat.

ABSLBANETFADANIENTADANIGREENADANIPORTSALLETECAPOLLOAPOLLOHOSPBANKADDBANKBEESBANKBETABANKBETFBANKETFBANKIETFBANKINDIABANKNIFTY1BANKPSUBBNPNBETFBNKETFAXISCONSUMERDRREDDYEBANKNIFTYESGFINIETFGROWWMC150GROWWMETALGROWWPSUBKGROWWRAILGROWWRLTYGROWWSC250HCLTECHHDFCMID150HDFCNIF100HDFCNIFBANHDFCPSUBKHDFCPVTBANHDFCSML250HINDALCOHTMEDIAINFYLICNFNHGPLICNMID100LOWVOLLOWVOL1LOWVOLIETFMETALMETALIETFMID150MID150BEESMID150CASEMIDCAPMIDCAPADDMIDCAPBETAMIDCAPETFMIDCAPIETFMIDQ50ADDMIDSMALLMOM100MONIFTY100MOREALTYMOSMALL250NIF100BEESNIF100IETFNIFTY100EWNPBETPSUBANKPSUBANKADDPSUBNKBEESPSUBNKIETFPVTBANIETFPVTBANKADDSBIBPBSBINMID150SETFNIFBKSMALL250SMALLADDSMALLCAPSML100CASETCSTOP100CASEWIPROCapital GoodsFinancial Services
Taking Stock: Markets rally for 4th straight day; Sensex surges 509 pts, Nifty above 23,100
positive
Moneycontrol NaNd ago

Taking Stock: Markets rally for 4th straight day; Sensex surges 509 pts, Nifty above 23,100

Biggest Nifty gainers were Wipro, Hindalco Industries, HCL Technologies, TCS, Infosys, while losers included Dr Reddy's Laboratories, Adani Enterprises, Interglobe Aviatoion, Apollo Hospitals, M&M.

ADANIENTAPOLLOAPOLLOHOSPDRREDDYESGGROWWCAPMHCLTECHHDFCNIF100HINDALCOINFYLICNFNHGPLICNMID100LOWVOLLOWVOL1LOWVOLIETFMIDSMALLM&MMONIFTY100NIF100BEESNIF100IETFNIFTY100EWSMALLCAPSML100CASETCSTOP100CASEWIPROAutomobile and Auto ComponentsCapital Goods
Neutral Lupin; target of Rs 2520: Motilal Oswal
positive
Moneycontrol NaNd ago

Neutral Lupin; target of Rs 2520: Motilal Oswal

Motilal Oswal recommended Neutral rating on Lupin with a target price of Rs 2520 in its research report dated May 10, 2026.

LUPINMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEFinancial ServicesHealthcare
Buy Laurus Labs; target of Rs 1280: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Laurus Labs; target of Rs 1280: Motilal Oswal

Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 1280 in its research report dated March 19, 2026.

LAURUSLABSMOALPHA50MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEFinancial ServicesHealthcare
Buy Granules India; target of Rs 820: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Granules India; target of Rs 820: Motilal Oswal

Motilal Oswal is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 820 in its research report dated April 29, 2026.

GRANULESMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEFinancial ServicesHealthcare